|
US3966922A
(en)
|
1971-07-23 |
1976-06-29 |
Takeda Chemical Industries, Ltd. |
Composition for poultry and livestock
|
|
US3957980A
(en)
|
1972-10-26 |
1976-05-18 |
Pfizer Inc. |
Doxycycline parenteral compositions
|
|
JPS5418330B2
(enExample)
|
1973-03-16 |
1979-07-06 |
|
|
|
US4018889A
(en)
|
1976-01-02 |
1977-04-19 |
Pfizer Inc. |
Oxytetracycline compositions
|
|
US4126680A
(en)
|
1977-04-27 |
1978-11-21 |
Pfizer Inc. |
Tetracycline antibiotic compositions
|
|
US4443442A
(en)
|
1979-12-21 |
1984-04-17 |
Skillern Scott D |
Method and composition for treatment of acne vulgaris
|
|
US4376118A
(en)
|
1980-10-06 |
1983-03-08 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt
|
|
US4369172A
(en)
|
1981-12-18 |
1983-01-18 |
Forest Laboratories Inc. |
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
|
|
US4376172A
(en)
*
|
1982-02-01 |
1983-03-08 |
Cincinnati Milacron Inc. |
Closed loop control of compressible fluid addition to a mixture of such fluid and a liquid
|
|
US4806529A
(en)
|
1982-11-18 |
1989-02-21 |
Trustees Of Tufts College, Tufts University |
Tetracycline activity enhancement
|
|
US4764377A
(en)
|
1983-10-07 |
1988-08-16 |
The Forsyth Dental Infirmary For Children |
Intra-pocket drug delivery devices for treatment of periodontal diseases
|
|
US4935412A
(en)
|
1983-12-29 |
1990-06-19 |
The Research Foundation Of State University Of New York |
Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
|
|
US4925833A
(en)
|
1983-12-29 |
1990-05-15 |
The Research Foundation Of State University Of New York |
Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
|
|
US4701320A
(en)
|
1984-11-29 |
1987-10-20 |
Lederle (Japan), Ltd. |
Composition stably containing minocycline for treating periodontal diseases
|
|
US5209978A
(en)
|
1985-12-26 |
1993-05-11 |
Taisho Pharmaceutical Co., Ltd. |
Seamless soft capsule and production thereof
|
|
US5389677B1
(en)
|
1986-12-23 |
1997-07-15 |
Tristrata Inc |
Method of treating wrinkles using glycalic acid
|
|
AU618517B2
(en)
|
1986-12-23 |
1992-01-02 |
Eugene J. Van Scott |
Additives enhancing topical actions of therapeutic agents
|
|
US4792448A
(en)
|
1987-06-11 |
1988-12-20 |
Pfizer Inc. |
Generic zero order controlled drug delivery system
|
|
HU198173B
(en)
|
1987-09-18 |
1989-08-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing doxycycline
|
|
US4837030A
(en)
|
1987-10-06 |
1989-06-06 |
American Cyanamid Company |
Novel controlled release formulations of tetracycline compounds
|
|
US5211958A
(en)
|
1987-11-30 |
1993-05-18 |
Gist-Brocades, N.V. |
Pharmaceutical composition and process for its preparation
|
|
US5277916A
(en)
|
1988-02-01 |
1994-01-11 |
F. H. Faulding & Co., Ltd. |
Tetracycline dosage form
|
|
US5202128A
(en)
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
|
ATE128959T1
(de)
|
1989-01-24 |
1995-10-15 |
Spi Polyols Inc |
Kryoschützende kristalline sorbitolkügelchen.
|
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
US5122519A
(en)
|
1989-06-27 |
1992-06-16 |
American Cyanamid Company |
Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
|
|
EP0489843A4
(en)
*
|
1989-08-28 |
1992-08-12 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
EP0418596A3
(en)
|
1989-09-21 |
1991-10-23 |
American Cyanamid Company |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
|
|
EP0418597A3
(en)
|
1989-09-21 |
1991-11-27 |
American Cyanamid Company |
Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
|
|
IL95423A
(en)
|
1989-09-21 |
1994-11-11 |
American Cyanamid Co |
Pulsatile once-a-day delivery systems for minocycline
|
|
JP3016587B2
(ja)
|
1989-12-04 |
2000-03-06 |
ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク |
非ステロイド抗炎症剤及びテトラサイクリンの配合
|
|
US5230895A
(en)
|
1990-05-01 |
1993-07-27 |
Copley Pharmaceutical Inc. |
Sustained released delivery system for use in the periodontal pocket
|
|
US5188836A
(en)
|
1990-07-27 |
1993-02-23 |
Warner-Lambert Company |
Sustained release formulations
|
|
FI922107A0
(fi)
|
1991-05-10 |
1992-05-08 |
Faulding F H & Co Ltd |
Mikrokapselkomposition och foerfarande.
|
|
DE69224294T2
(de)
|
1991-10-16 |
1998-08-20 |
Richardson Vicks Inc |
Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln
|
|
US5167964A
(en)
|
1992-02-14 |
1992-12-01 |
Warner-Lambert Company |
Semi-enteric drug delivery systems and methods for preparing same
|
|
US5262173A
(en)
|
1992-03-02 |
1993-11-16 |
American Cyanamid Company |
Pulsatile once-a-day delivery systems for minocycline
|
|
US5217493A
(en)
|
1992-03-11 |
1993-06-08 |
Board Of Regents, The University Of Texas System |
Antibacterial coated medical implants
|
|
US5582837A
(en)
|
1992-03-25 |
1996-12-10 |
Depomed, Inc. |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
|
|
CA2132012C
(en)
|
1992-03-25 |
2003-04-22 |
John W. Shell |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
|
|
US5518730A
(en)
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
|
EP0653935B1
(en)
|
1992-08-05 |
2002-05-08 |
F.H. FAULDING & CO. LIMITED |
Pelletised pharmaceutical composition
|
|
WO1995022529A1
(en)
|
1994-02-17 |
1995-08-24 |
Pfizer Inc. |
9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
|
|
KR960016882A
(ko)
|
1994-11-01 |
1996-06-17 |
강재헌 |
치주염치료를 위한 서방출형 생분해성 제제
|
|
US5674539A
(en)
|
1994-12-09 |
1997-10-07 |
Tomas; Robert E. |
Method of treating skin and composition
|
|
WO1996034852A1
(en)
|
1995-05-03 |
1996-11-07 |
Pfizer, Inc. |
Novel tetracycline derivatives
|
|
AUPN605795A0
(en)
|
1995-10-19 |
1995-11-09 |
F.H. Faulding & Co. Limited |
Analgesic pharmaceutical composition
|
|
US5814331A
(en)
|
1995-11-13 |
1998-09-29 |
Holen; Sheldon |
Process for inhibiting pathogenic bacteria in the oral cavity and for binding peptide growth factors on surfaces
|
|
US5783212A
(en)
*
|
1996-02-02 |
1998-07-21 |
Temple University--of the Commonwealth System of Higher Education |
Controlled release drug delivery system
|
|
US5789395A
(en)
*
|
1996-08-30 |
1998-08-04 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
|
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
US8828432B2
(en)
*
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
US6429204B1
(en)
|
1997-01-15 |
2002-08-06 |
University Of Miami |
Method of inhibiting cancer growth
|
|
ATE302597T1
(de)
|
1997-06-06 |
2005-09-15 |
Depomed Inc |
Im magen verweilende orale dosierungsformen von wasserlöslichen arzneistoffen mit kontrollierter freisetzung
|
|
PL337813A1
(en)
|
1997-06-11 |
2000-09-11 |
Procter & Gamble |
Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
|
|
ES2234139T3
(es)
|
1997-08-11 |
2005-06-16 |
Alza Corporation |
Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica.
|
|
US5908838A
(en)
|
1998-02-19 |
1999-06-01 |
Medics Pharmaceutical Corporation |
Method for the treatment of acne
|
|
KR100296413B1
(ko)
*
|
1998-04-01 |
2001-11-14 |
김선진 |
세파클러함유서방성정제
|
|
DK1676579T3
(da)
|
1998-05-08 |
2009-03-16 |
Univ Miami |
Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea
|
|
US6015804A
(en)
*
|
1998-09-11 |
2000-01-18 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds to enhance interleukin-10 production
|
|
US6506740B1
(en)
|
1998-11-18 |
2003-01-14 |
Robert A. Ashley |
4-dedimethylaminotetracycline derivatives
|
|
US6087382A
(en)
|
1999-03-17 |
2000-07-11 |
Bonner, Jr.; Ernest L. |
Method for treatment of reactive arthritis or bursitis
|
|
MX339071B
(es)
*
|
1999-03-31 |
2016-05-09 |
Janssen Pharmaceutica Nv |
Almidon pregelatinizado en una formulacion de liberacion controlada.
|
|
WO2000059481A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
|
|
US6673843B2
(en)
|
1999-06-30 |
2004-01-06 |
Emory University |
Curcumin and curcuminoid inhibition of angiogenesis
|
|
US6497902B1
(en)
|
1999-12-01 |
2002-12-24 |
The Regents Of The University Of Michigan |
Ionically crosslinked hydrogels with adjustable gelation time
|
|
DK1242055T3
(da)
|
1999-12-23 |
2008-07-21 |
Pfizer Prod Inc |
Hydrogelstyret doseringsform til lægemidler
|
|
JP3888064B2
(ja)
*
|
2000-01-27 |
2007-02-28 |
田辺製薬株式会社 |
徐放性製剤およびその製法
|
|
AU2001281485A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Genetics Institute, Inc. |
Thermoreversible polymers for delivery and retention of osteoinductive proteins
|
|
US7211267B2
(en)
|
2001-04-05 |
2007-05-01 |
Collagenex Pharmaceuticals, Inc. |
Methods of treating acne
|
|
EP1716856A3
(en)
*
|
2001-04-05 |
2009-02-18 |
Collagenex Pharmaceuticals, Inc. |
The treatment of acne
|
|
CA2447008A1
(en)
|
2001-04-05 |
2002-10-24 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
US6585997B2
(en)
*
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
|
CA2409552A1
(en)
*
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030082120A1
(en)
|
2001-10-26 |
2003-05-01 |
Milstein Harold J. |
Method for reducing systemic effects of aging, effects of aging on the skin, and incidence of skin damage from sun exposure using antibiotics of the tetracycline family
|
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
|
WO2003088906A2
(en)
|
2002-04-16 |
2003-10-30 |
Collagenex Pharmaceuticals, Inc. |
Methods of simultaneously treating ocular rosacea and acne rosacea
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US20040127471A1
(en)
|
2002-09-17 |
2004-07-01 |
Barry Reisberg |
Methods of treating age associated memory impairment (AAMI), mild cognitive impairment (MCI), and dementias with cell cycle inhibitors
|
|
JP4443834B2
(ja)
*
|
2003-01-24 |
2010-03-31 |
杏林製薬株式会社 |
徐放性錠剤およびその製造方法
|
|
WO2004078111A2
(en)
|
2003-03-06 |
2004-09-16 |
Ranbaxy Laboratories Limited |
Extended release minocycline compositions and processes for their preparation
|
|
CA2521885C
(en)
*
|
2003-04-07 |
2013-06-25 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
US6863830B1
(en)
|
2003-08-21 |
2005-03-08 |
Biolab Services, Inc. |
Dual layer tablet, method of making and use thereof
|
|
EP1684768A4
(en)
|
2003-11-06 |
2007-06-06 |
Univ New York State Res Found |
METHOD FOR TREATING ECCEM
|
|
US7943585B2
(en)
|
2003-12-22 |
2011-05-17 |
Sandoz, Inc. |
Extended release antibiotic composition
|
|
GB2414668B
(en)
|
2004-06-03 |
2009-07-29 |
Dexcel Ltd |
Tetracycline modified release delivery system
|
|
US20080242642A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US20080241235A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US7919483B2
(en)
*
|
2005-06-24 |
2011-04-05 |
Medicis Pharmaceutical Corporation |
Method for the treatment of acne
|
|
US8252776B2
(en)
*
|
2007-04-02 |
2012-08-28 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US7544373B2
(en)
*
|
2007-04-02 |
2009-06-09 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US7541347B2
(en)
*
|
2007-04-02 |
2009-06-02 |
Medicis Pharmaceutical Coropration |
Minocycline oral dosage forms for the treatment of acne
|
|
US20080241197A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline dosage forms for the treatment of acne
|